Dewey Steadman
Stock Analyst at Canaccord Genuity
(0.65)
# 4,113
Out of 5,141 analysts
34
Total ratings
41.67%
Success rate
-25.59%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Dewey Steadman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANIP ANI Pharmaceuticals | Maintains: Buy | $75 → $70 | $77.77 | -9.99% | 5 | Nov 12, 2018 | |
| PCRX Pacira BioSciences | Maintains: Hold | $45 → $49 | $23.22 | +111.02% | 14 | Oct 2, 2018 | |
| AMRX Amneal Pharmaceuticals | Maintains: Hold | $18 → $21 | $14.50 | +44.83% | 1 | Aug 14, 2018 | |
| ACET Adicet Bio | Downgrades: Sell | n/a | $7.14 | - | 4 | Apr 19, 2018 | |
| LPCN Lipocine | Downgrades: Hold | n/a | $9.80 | - | 3 | Jan 11, 2018 | |
| SVRA Savara | Maintains: Buy | $18 → $25 | $5.53 | +352.08% | 2 | Oct 30, 2017 | |
| PRGO Perrigo Company | Maintains: Buy | $88 → $100 | $14.97 | +568.00% | 5 | Sep 13, 2017 |
ANI Pharmaceuticals
Nov 12, 2018
Maintains: Buy
Price Target: $75 → $70
Current: $77.77
Upside: -9.99%
Pacira BioSciences
Oct 2, 2018
Maintains: Hold
Price Target: $45 → $49
Current: $23.22
Upside: +111.02%
Amneal Pharmaceuticals
Aug 14, 2018
Maintains: Hold
Price Target: $18 → $21
Current: $14.50
Upside: +44.83%
Adicet Bio
Apr 19, 2018
Downgrades: Sell
Price Target: n/a
Current: $7.14
Upside: -
Lipocine
Jan 11, 2018
Downgrades: Hold
Price Target: n/a
Current: $9.80
Upside: -
Savara
Oct 30, 2017
Maintains: Buy
Price Target: $18 → $25
Current: $5.53
Upside: +352.08%
Perrigo Company
Sep 13, 2017
Maintains: Buy
Price Target: $88 → $100
Current: $14.97
Upside: +568.00%